These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 1810359

  • 41. Fluvoxamine does not interact with alcohol or potentiate alcohol-related impairment of cognitive function.
    van Harten J, Stevens LA, Raghoebar M, Holland RL, Wesnes K, Cournot A.
    Clin Pharmacol Ther; 1992 Oct; 52(4):427-35. PubMed ID: 1424416
    [Abstract] [Full Text] [Related]

  • 42. Study of the effect of nortriptyline and fluvoxamine on psychomotor functions in healthy volunteers.
    Khade A, Bashir MS, Kale AS, Turankar A.
    Indian J Psychol Med; 2010 Jul; 32(2):104-7. PubMed ID: 21716778
    [Abstract] [Full Text] [Related]

  • 43. Early predictors of two month response with mianserin and selective serotonin reuptake inhibitors and influence of definition of outcome on prediction.
    Berlin I, Lavergne F.
    Eur Psychiatry; 1998 May; 13(3):138-42. PubMed ID: 19698616
    [Abstract] [Full Text] [Related]

  • 44. The effects of mianserin therapy on plasma renin activity in depressed patients.
    Altamura AC, Bareggi SR, Invernizzi G, Morganti A, Zanchetti A.
    Biol Psychiatry; 1986 Nov; 21(13):1331-4. PubMed ID: 3530342
    [No Abstract] [Full Text] [Related]

  • 45. Prediction of plasma concentrations of mianserin and desmethylmianserin at steady state from those after an initial dose of mianserin.
    Otani K, Mihara K, Okada M, Tanaka O, Kaneko S, Fukushima Y.
    Ther Drug Monit; 1993 Apr; 15(2):118-21. PubMed ID: 8503139
    [Abstract] [Full Text] [Related]

  • 46. Mianserin in the treatment of elderly depressives.
    Magni G.
    J Am Geriatr Soc; 1987 Jul; 35(7):707-8. PubMed ID: 3584780
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Treatment of vomiting attacks in patients with williams syndrome using mianserin and telazine.
    Ceylan ME, Yavas E.
    West Indian Med J; 2014 Mar; 63(2):209. PubMed ID: 25303267
    [No Abstract] [Full Text] [Related]

  • 52. Obesity and psychotropics.
    Nihalani N, Schwartz TL, Siddiqui UA, Megna JL.
    CNS Neurosci Ther; 2012 Jan; 18(1):57-63. PubMed ID: 22070396
    [Abstract] [Full Text] [Related]

  • 53. Weight gain, obesity, and psychotropic prescribing.
    Nihalani N, Schwartz TL, Siddiqui UA, Megna JL.
    J Obes; 2011 Jan; 2011():893629. PubMed ID: 21318056
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. The effects of psychomotor performance of fluvoxamine versus mianserin in depressed patients in general practice.
    Moon CA, Jesinger DK.
    Br J Clin Pract; 1991 Jan; 45(4):259-62. PubMed ID: 1810359
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. A controlled study of mianserin in moderately to severely depressed outpatients.
    Carman JS, Ahdieh H, Wyatt-Knowles E, Warga E, Panagides J.
    Psychopharmacol Bull; 1991 Jan; 27(2):135-9. PubMed ID: 1924659
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.